1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This non-competitive Notice of Funding Opportunity (NOFO) is intended to fund a single award to the current awardee institution of the Accelerating Medicines Partnership in Common Metabolic Diseases Knowledge Portal (AMP CMD KP), the Broad Institute, Inc. The AMP CMD program is a collaborative partnership between the NIH, pharmaceutical companies, and nonprofit organizations to develop new models for identifying and validating promising biological targets to serve as biomarkers and/or for drug discovery (www.nih.gov/research-training/accelerating-medicines-partnership-amp/type-2-diabetes). This is a one-time NOFO to provide funds to the AMP CMD KP to continue the development and maintenance of the web portal and underlying, curated knowledge base; which serves as the flagship resource encompassing the myriad types of data and information that provide an understanding of the biological heterogeneity in patients with CMDs and their related complications. In its next five-year period, the AMP CMD KP will be expected to continue its expansion of its datasets and traits, import additional data types, deploy additional analytical and visualization tools, and increase its utility to a more diverse user base, and to develop a framework for independent sustainability. The application will be peer-reviewed and if it is not a meritorious application, it will not be funded.
Funding Opportunity Number: RFA-DK-26-313. Assistance Listing: 93.847. Funding Instrument: CA. Category: HL. Award Amount: Up to $2M per award.
Get alerted about grants like this
Save a search for “National Institutes of Health” or related topics and get emailed when new opportunities appear.
Search similar grants →Based on current listing details, eligibility includes: Eligible applicants: Others (see text field entitled Additional Information on Eligibility for clarification). Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Only the following applicant is eligible to apply for this single source funding: The Broad Institute, Inc. Please refer to Section I. Notice of Funding Opportunity Information for more details. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Up to $2M per award Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is March 10, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Past winners and funding trends for this program
Establishing a Center for the Advancement of SUD Pharmacotherapeutics (U54) is sponsored by National Institutes of Health (NIDA). Planning NOFO to establish a translational center for SUD pharmacotherapeutic development, training, and outreach. Application snapshot: target deadline March 10, 2026; published funding information Approximately $3,000,000 for first year, one award; eligibility guidance Governments, nonprofits, educational institutions, tribal organizations. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
To promote research investigating protective and pathogenic mechanisms at the nexus of mitochondria function and aging in the context of HIV infection and exposure to addictive substances. We anticipate this foundational knowledge could be leveraged to develop targeted therapies and improve outcomes in people aging with HIV, substance use and addiction. Funding Opportunity Number: RFA-DA-26-010. Assistance Listing: 93.279. Funding Instrument: G. Category: ED,HL.